ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/07/18 | 1,415 | 1,430 | 1,392 | 1,430 | +10 | +0.7% | 1,987,900 |
2023/07/14 | 1,436 | 1,453 | 1,404 | 1,420 | -27 | -1.9% | 1,773,900 |
2023/07/13 | 1,429 | 1,447 | 1,371 | 1,447 | +33 | +2.3% | 3,858,600 |
2023/07/12 | 1,525 | 1,536 | 1,400 | 1,414 | -112 | -7.3% | 5,008,900 |
2023/07/11 | 1,530 | 1,565 | 1,520 | 1,526 | +10 | +0.7% | 2,530,900 |
2023/07/10 | 1,491 | 1,550 | 1,491 | 1,516 | +10 | +0.7% | 3,331,500 |
2023/07/07 | 1,537 | 1,566 | 1,486 | 1,506 | -49 | -3.2% | 4,742,700 |
2023/07/06 | 1,568 | 1,624 | 1,554 | 1,555 | -26 | -1.6% | 5,366,400 |
2023/07/05 | 1,568 | 1,607 | 1,541 | 1,581 | +2 | +0.1% | 5,520,500 |
2023/07/04 | 1,524 | 1,627 | 1,515 | 1,579 | +68 | +4.5% | 13,322,400 |
2023/07/03 | 1,543 | 1,546 | 1,483 | 1,511 | +11 | +0.7% | 10,827,500 |
2023/06/30 | 1,453 | 1,526 | 1,424 | 1,500 | +59 | +4.1% | 18,344,000 |
2023/06/29 | 1,600 | 1,610 | 1,390 | 1,441 | -519 | -26.5% | 52,341,400 |
2023/06/28 | 1,960 | 1,960 | 1,960 | 1,960 | -500 | -20.3% | 156,300 |
2023/06/27 | 2,460 | 2,460 | 2,460 | 2,460 | -700 | -22.2% | 158,400 |
2023/06/26 | 2,957 | 3,175 | 2,948 | 3,160 | +188 | +6.3% | 1,553,500 |
2023/06/23 | 3,020 | 3,030 | 2,964 | 2,972 | -33 | -1.1% | 811,800 |
2023/06/22 | 2,950 | 3,015 | 2,931 | 3,005 | +47 | +1.6% | 883,800 |
2023/06/21 | 2,907 | 3,040 | 2,886 | 2,958 | +101 | +3.5% | 1,905,900 |
2023/06/20 | 2,839 | 2,873 | 2,775 | 2,857 | -31 | -1.1% | 1,312,300 |
2023/06/19 | 2,896 | 2,911 | 2,831 | 2,888 | +2 | +0.1% | 1,022,600 |
2023/06/16 | 2,818 | 2,904 | 2,816 | 2,886 | +46 | +1.6% | 1,144,900 |
2023/06/15 | 2,971 | 2,983 | 2,802 | 2,840 | -158 | -5.3% | 1,925,000 |
2023/06/14 | 2,970 | 3,025 | 2,946 | 2,998 | +30 | +1% | 762,400 |
2023/06/13 | 3,025 | 3,070 | 2,952 | 2,968 | -37 | -1.2% | 1,052,500 |
2023/06/12 | 2,947 | 3,025 | 2,929 | 3,005 | +45 | +1.5% | 718,900 |
2023/06/09 | 2,998 | 3,030 | 2,952 | 2,960 | -15 | -0.5% | 636,500 |
2023/06/08 | 2,954 | 3,010 | 2,931 | 2,975 | -40 | -1.3% | 990,700 |
2023/06/07 | 3,055 | 3,075 | 2,999 | 3,015 | -55 | -1.8% | 724,300 |
2023/06/06 | 3,085 | 3,095 | 3,035 | 3,070 | +10 | +0.3% | 598,000 |
2023/06/05 | 3,070 | 3,080 | 3,005 | 3,060 | +35 | +1.2% | 678,500 |
2023/06/02 | 3,090 | 3,115 | 3,005 | 3,025 | -90 | -2.9% | 956,200 |
2023/06/01 | 3,105 | 3,160 | 3,090 | 3,115 | -20 | -0.6% | 470,100 |
2023/05/31 | 3,145 | 3,185 | 3,115 | 3,135 | -10 | -0.3% | 915,600 |
2023/05/30 | 3,010 | 3,165 | 2,995 | 3,145 | +105 | +3.5% | 1,105,300 |
2023/05/29 | 3,100 | 3,110 | 3,020 | 3,040 | -75 | -2.4% | 1,288,100 |
2023/05/26 | 3,135 | 3,175 | 3,090 | 3,115 | -5 | -0.2% | 1,039,600 |
2023/05/25 | 3,060 | 3,120 | 3,040 | 3,120 | +85 | +2.8% | 1,278,800 |
2023/05/24 | 2,953 | 3,070 | 2,950 | 3,035 | +78 | +2.6% | 1,897,500 |
2023/05/23 | 2,903 | 2,966 | 2,861 | 2,957 | +68 | +2.4% | 1,825,100 |
2023/05/22 | 2,818 | 2,894 | 2,802 | 2,889 | +71 | +2.5% | 848,400 |
2023/05/19 | 2,863 | 2,878 | 2,787 | 2,818 | -57 | -2% | 1,135,900 |
2023/05/18 | 2,725 | 2,900 | 2,725 | 2,875 | +124 | +4.5% | 1,897,000 |
2023/05/17 | 2,695 | 2,762 | 2,669 | 2,751 | +16 | +0.6% | 855,000 |
2023/05/16 | 2,827 | 2,830 | 2,701 | 2,735 | -85 | -3% | 1,115,400 |
2023/05/15 | 2,877 | 2,913 | 2,791 | 2,820 | -7 | -0.2% | 1,237,800 |
2023/05/12 | 2,790 | 2,846 | 2,768 | 2,827 | +22 | +0.8% | 1,062,800 |
2023/05/11 | 2,796 | 2,825 | 2,779 | 2,805 | -8 | -0.3% | 651,300 |
2023/05/10 | 2,859 | 2,874 | 2,796 | 2,813 | -23 | -0.8% | 1,092,800 |
2023/05/09 | 2,851 | 2,880 | 2,819 | 2,836 | -22 | -0.8% | 1,076,000 |
301~
350
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム